HRP20040066B1 - Solid composition containing bacillus-type non-pathogenic bacterial spores - Google Patents

Solid composition containing bacillus-type non-pathogenic bacterial spores

Info

Publication number
HRP20040066B1
HRP20040066B1 HR20040066A HRP20040066A HRP20040066B1 HR P20040066 B1 HRP20040066 B1 HR P20040066B1 HR 20040066 A HR20040066 A HR 20040066A HR P20040066 A HRP20040066 A HR P20040066A HR P20040066 B1 HRP20040066 B1 HR P20040066B1
Authority
HR
Croatia
Prior art keywords
pathogenic bacterial
composition containing
solid composition
type non
bacterial spores
Prior art date
Application number
HR20040066A
Other languages
English (en)
Croatian (hr)
Inventor
Prato Tiziano
Original Assignee
Sanofi-Synthelabo Otc S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo Otc S.P.A. filed Critical Sanofi-Synthelabo Otc S.P.A.
Publication of HRP20040066A2 publication Critical patent/HRP20040066A2/hr
Publication of HRP20040066B1 publication Critical patent/HRP20040066B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
HR20040066A 2001-07-27 2004-01-22 Solid composition containing bacillus-type non-pathogenic bacterial spores HRP20040066B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (2)

Publication Number Publication Date
HRP20040066A2 HRP20040066A2 (en) 2004-06-30
HRP20040066B1 true HRP20040066B1 (en) 2012-02-29

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040066A HRP20040066B1 (en) 2001-07-27 2004-01-22 Solid composition containing bacillus-type non-pathogenic bacterial spores

Country Status (32)

Country Link
US (2) US8039006B2 (xx)
EP (1) EP1429808B1 (xx)
JP (1) JP4913986B2 (xx)
KR (2) KR100970787B1 (xx)
CN (1) CN1323720C (xx)
AT (1) ATE462448T1 (xx)
AU (1) AU2002333278B2 (xx)
BR (1) BRPI0211453B1 (xx)
CA (1) CA2454389C (xx)
CO (1) CO5560587A2 (xx)
CY (1) CY1112608T1 (xx)
DE (1) DE60235819D1 (xx)
DK (1) DK1429808T3 (xx)
EA (1) EA006847B1 (xx)
ES (1) ES2356325T3 (xx)
GE (2) GEP20063721B (xx)
HK (1) HK1061644A1 (xx)
HR (1) HRP20040066B1 (xx)
HU (1) HU229652B1 (xx)
IL (2) IL159807A0 (xx)
IT (1) ITMI20011632A1 (xx)
MA (1) MA27051A1 (xx)
MX (1) MXPA04000835A (xx)
NO (1) NO332656B1 (xx)
NZ (1) NZ530743A (xx)
PL (1) PL209647B1 (xx)
PT (1) PT1429808E (xx)
SI (1) SI1429808T1 (xx)
TN (1) TNSN04018A1 (xx)
UA (1) UA81225C2 (xx)
WO (1) WO2003011341A1 (xx)
ZA (1) ZA200400440B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
CA2720554C (en) 2008-04-07 2016-11-08 Bayer Cropscience Ag Combinations of biological control agents and insecticides or fungicides
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
WO2011120530A1 (en) * 2010-03-31 2011-10-06 Lifecycle Phama A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CA3212215A1 (en) * 2012-11-23 2014-05-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
AU2014212004B2 (en) 2013-02-04 2018-09-20 Seres Therapeutics, Inc. Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
CA2906921A1 (en) 2013-03-15 2014-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
CA3203756A1 (en) 2013-11-25 2015-05-28 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
JP2020530840A (ja) 2017-08-14 2020-10-29 セレス セラピューティクス インコーポレイテッド 胆汁うっ滞性疾患を治療するための組成物及び方法
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
US4935353A (en) * 1984-10-09 1990-06-19 Agricultural Genetics Company, Limited Preparation of strains of Bacillus thuringiensis having an improved activity against certain lepidopterous pests and novel strain produced thereby
WO1999049877A2 (en) * 1998-04-01 1999-10-07 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3707160A1 (de) 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
WO1995022962A1 (en) * 1994-02-23 1995-08-31 Bm Research A/S Controlled release composition
WO1995034291A1 (en) * 1994-06-15 1995-12-21 Dumex-Alpharma A/S Pellets
DE4442255A1 (de) 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) * 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
US4935353A (en) * 1984-10-09 1990-06-19 Agricultural Genetics Company, Limited Preparation of strains of Bacillus thuringiensis having an improved activity against certain lepidopterous pests and novel strain produced thereby
WO1999049877A2 (en) * 1998-04-01 1999-10-07 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions

Also Published As

Publication number Publication date
BRPI0211453B1 (pt) 2018-04-03
CN1323720C (zh) 2007-07-04
GEP20063721B (en) 2006-01-10
CA2454389A1 (fr) 2003-02-13
TNSN04018A1 (fr) 2006-06-01
US20040241772A1 (en) 2004-12-02
SI1429808T1 (sl) 2010-11-30
EP1429808B1 (fr) 2010-03-31
NO332656B1 (no) 2012-11-26
EP1429808A1 (fr) 2004-06-23
IL159807A0 (en) 2004-06-20
WO2003011341A1 (fr) 2003-02-13
KR20090099022A (ko) 2009-09-18
ATE462448T1 (de) 2010-04-15
HRP20040066A2 (en) 2004-06-30
US8551498B2 (en) 2013-10-08
GEP20053721B (en) 2006-01-10
DE60235819D1 (de) 2010-05-12
IL159807A (en) 2010-05-31
CA2454389C (fr) 2011-07-12
MXPA04000835A (es) 2004-05-14
MA27051A1 (fr) 2004-12-20
DK1429808T3 (da) 2010-07-19
UA81225C2 (en) 2007-12-25
HUP0402024A3 (en) 2005-06-28
ITMI20011632A0 (it) 2001-07-27
NO20040347L (no) 2004-03-26
ES2356325T3 (es) 2011-04-07
US20120009167A1 (en) 2012-01-12
EA200400072A1 (ru) 2004-08-26
CO5560587A2 (es) 2005-09-30
BR0211453A (pt) 2004-08-17
PL209647B1 (pl) 2011-09-30
KR100970787B1 (ko) 2010-07-16
PL366984A1 (en) 2005-02-07
JP2004538311A (ja) 2004-12-24
JP4913986B2 (ja) 2012-04-11
US8039006B2 (en) 2011-10-18
CN1558776A (zh) 2004-12-29
ZA200400440B (en) 2005-03-30
HU229652B1 (en) 2014-03-28
ITMI20011632A1 (it) 2003-01-27
EA006847B1 (ru) 2006-04-28
HK1061644A1 (en) 2004-09-30
HUP0402024A2 (hu) 2005-01-28
NZ530743A (en) 2005-08-26
AU2002333278B2 (en) 2007-05-31
KR20040032868A (ko) 2004-04-17
PT1429808E (pt) 2010-06-23
CY1112608T1 (el) 2016-02-10

Similar Documents

Publication Publication Date Title
HRP20040066B1 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
ATE425244T1 (de) Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
MY125941A (en) New lactobacillus strains preventing diarrhoea caused by pathogenic bacteria
AU2001289922A1 (en) Microbiological culture for triggering microbiological processes in water
NO20054765L (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
AU2002333278A1 (en) Solid composition containing Bacillus-type non-pathogenic bacterial spores
RS50310B (sr) Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
TR200200300T2 (tr) İshali önlemeye elverişli bifidobakteriler.
ATE474582T1 (de) Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
DE69632373D1 (de) Selektive Medien zur Kultivierung und Isolierung von Gram-negativen Bakterien, antibiotische Zusammensetzung
DE10084438T1 (de) Boden verbessernde, als Düngemittel wirkende und langsam Biopestizide freisetzende Zusammensetzung
WO2006066224A3 (en) Virulence targeted antibiotics
YU46804A (sh) Antibiotici ge 81112 faktor a, ge 81112 faktor b,ge 81112 faktor b1, njihove farmaceutske soli i preparati i njihova primena
UA62872C2 (en) Agent to antiseptisize a raw material and production environment (variants)
KR950029350A (ko) 유제품으로부터 비피도박테리아의 선발과 계수를 위한 특정 숙주감염 특이성을 지닌 파지가 함유된 선택배지
RU2000125440A (ru) Способ определения чувствительности микроорганизмов к антибиотикам при гнойной инфекции

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190624

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200721

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210723

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20220726